Results 231 to 240 of about 2,128,083 (311)

Oncoplastic Surgery Versus Total Breast Reconstruction in Locally Advanced and Multicentric Carcinomas. A Matched Comparative Cohort Study of Oncologic and Aesthetic Outcomes

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background/Objective This study aimed to compare extreme oncoplastic surgery (EO‐partial breast reconstruction for tumors > 5 cm or multicentric lesions) with extreme reconstruction (ER‐mastectomy with reconstruction for tumors >5 cm or multicentric lesions).
Aline Regina Nunes‐Reis   +4 more
wiley   +1 more source

Rethinking Age Limits in Oncoplastic Breast Surgery: Long‐Term Outcomes of Oncoplastic Surgery in Elderly Patients

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Methods Although OBS is a well‐established approach, evidence regarding its long‐term safety and outcomes in older women remains limited. We performed a retrospective analysis to identify patients ≥ 60 years who underwent OBS for breast cancer between 2001 and 2014.
Francesca De Lorenzi   +9 more
wiley   +1 more source

Impact of Body Mass Index on Surgical Outcomes After Delayed Breast Reconstruction

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Obesity is associated with increased postoperative morbidity in surgery. However, its specific impact on complications following delayed breast reconstruction (DBR) remains insufficiently documented. Methods We conducted a retrospective single‐center study including patients who underwent first‐time delayed breast ...
Anaïs Benziane   +9 more
wiley   +1 more source

Association of Adjuvant Radiotherapy De‐Escalation With Outcomes Following Oncoplastic Breast‐Conserving Surgery

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Adjuvant radiotherapy (RT) following breast‐conserving surgery reduces local recurrence but can introduce reconstructive morbidity. Although recent trials support the safe omission of RT in selected patients, its impact on surgical and patient‐reported outcomes following oncoplastic breast‐conserving surgery (OPBCS) remains poorly ...
Abbas M. Hassan   +9 more
wiley   +1 more source

Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple‐Positive Breast Cancer

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT To identify the determinants of the response to neoadjuvant systemic therapy (NST) in triple‐positive breast cancer (TPBC), we retrospectively enrolled 520 patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer who were treated at The First Affiliated Hospital of Chongqing Medical University between January 2015 ...
Lin‐Rui Miao   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy